Brief Mindfulness Practice for Long COVID Syndrome

Overseen By Maria Monroy, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of California, Davis

Disqualifiers: ICU admission, Respirator, Heart tests, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: 3 months

400 Participants Needed

Trial Summary

What is the purpose of this trial?

This study is testing a new brief mindfulness practice for people suffering from long COVID-19 symptoms. People suffering from long COVID are particularly vulnerable to negative emotions, as they must also cope with the long-term uncertainty of physical and psychological stress beyond the acute infection. The goal of the study is to measure the ability of a brief mindfulness practice to promote a sense of well-being in people suffering from long COVID.

Research Team

Javier E Lopez, MD

Principal Investigator

University of California, Davis

Eligibility Criteria

This trial is for English-speaking individuals who had mild to moderate COVID-19 over 3 months ago and are now experiencing long COVID symptoms like cough, loss of smell or taste, fever, body aches, brain fog, sleep issues, fatigue or mood changes. Participants must be able to engage in online sessions and surveys for 3 months.

Inclusion Criteria

I can join Zoom meetings and fill out surveys online for 3 months.

I had COVID-19 over 3 months ago and still feel symptoms like cough, fever, or tiredness.

I had COVID-19 over 3 months ago and still feel symptoms like cough, loss of smell, or tiredness.

Exclusion Criteria

I was in intensive care or had heart or lung tests.

Prisoners

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a brief mindfulness practice to promote well-being

3 months

Regular self-administered activities

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 months

Assessments at 1, 3, and 12 months

Treatment Details

Interventions

• Microdosing of mindfulness

Trial Overview The study is examining the effects of microdosing mindfulness as a brief practice aimed at improving well-being in people with long-term symptoms after recovering from COVID-19. It measures how this technique helps manage negative emotions associated with long COVID.

Participant Groups

Group I: Treatment Experimental Treatment 1 Intervention

Group II: Waitlist control Active Control 1 Intervention

Who Is Running the Clinical Trial?

University of California, Davis

Lead Sponsor

Trials

958

Recruited

4,816,000+